APP and early-onset autosomal dominant Alzheimer disease: Chronic opioid use also increases amyloid-beta (Aβ) production, a hallmark of Alzheimer’s disease, by elevating amyloid precursor protein and BACE1 expression, further enhancing neuroinflammation (Sil et al., 2021).